GBCS (Selectis Health) ROC (Joel Greenblatt) %: 151.94% (As of Mar. 2026) — 8683% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GBCS Selectis Health Inc GBCS
47 GF Score
Price $5.30
GF Value $2.14
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Selectis Health ROC (Joel Greenblatt) %?

Selectis Health GBCS +0.03% 47 ROC (Joel Greenblatt) % is 151.94% as of Mar. 2026, which is 8683% above its 10-year median of 1.73. GuruFocus rates GBCS with a GF Score™ of 47/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Selectis Health ranks better than 75.6% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Selectis Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 151.94%.

The historical rank and industry rank for Selectis Health's ROC (Joel Greenblatt) % or its related term are showing as below:

GBCS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -141.93   Med: 1.73   Max: 121.79
Current: 34.86

During the past 13 years, Selectis Health's highest ROC (Joel Greenblatt) % was 121.79%. The lowest was -141.93%. And the median was 1.73%.

GBCS's ROC (Joel Greenblatt) % is ranked better than
75.6% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 12.47 vs GBCS: 34.86

Selectis Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Selectis Health  (OTCPK:GBCS) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Selectis Health ROC (Joel Greenblatt) % Related Terms


Selectis Health ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Selectis Health's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selectis Health ROC (Joel Greenblatt) % Chart

Selectis Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 -0.46 -5.19 -1.22 2.78

Selectis Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.61 -1.18 13.88 -0.81 151.94

GBCS vs CCM, BMGL, AMS: ROC (Joel Greenblatt) % Comparison

For the Medical Care Facilities subindustry, Selectis Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Selectis Health ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Selectis Health's ROC (Joel Greenblatt) % falls into.


GBCS
47GF Score
Selectis Health Inc GBCS
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Selectis Health ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.277 + 0 + 4.171) - (6.38 + 0 + 6.856)
=-6.788

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.49 + 0 + 5.792) - (7.258 + 0 + 5.184)
=-4.16

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Selectis Health for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=31.44/( ( (23.076 + max(-6.788, 0)) + (18.308 + max(-4.16, 0)) )/ 2 )
=31.44/( ( 23.076 + 18.308 )/ 2 )
=31.44/20.692
=151.94 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 151.94% mean?
Selectis Health (GBCS) has a ROC (Joel Greenblatt) % of 151.94% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Selectis Health and its competitors. This is 8683% above median its historical median of 1.73. According to the industry distribution chart, Selectis Health ranks #163 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 24.4%.
Is Selectis Health's ROC (Joel Greenblatt) % too high?
Selectis Health's current ROC (Joel Greenblatt) % of 151.94% is 8683% above median its 10-year median of 1.73. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.47. Selectis Health's value of 151.94% is 1118.4% above this industry median. Based on the distribution chart, Selectis Health ranks #163 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Selectis Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's ROC (Joel Greenblatt) % compare to CCM and BMGL?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #163 out of 668 companies for ROC (Joel Greenblatt) %. This places Selectis Health in the top 24% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.47. Selectis Health's value of 151.94% is 1118.4% above this benchmark. While the company's 10-year median is 1.73 vs. the industry median of 12.47, Selectis Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selectis Health's current ROC (Joel Greenblatt) % of 151.94% is 1118.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Selectis Health and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current ROC (Joel Greenblatt) % is 151.94%, which is 8683% above median its own 10-year median of 1.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.30 — trading 147.7% above its estimated fair value. The current ROC (Joel Greenblatt) % is 151.94%, which is 8683% above median its 10-year median of 1.73 and 1118.4% above the Healthcare Providers & Services industry median of 12.47. Selectis Health's overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Selectis Health (GBCS), the current ROC (Joel Greenblatt) % is 151.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selectis Health (GBCS) Overvalued in 2026?

Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued. The current stock price of $5.30 is trading 147.7% above its estimated GF Value™ of $2.14. GuruFocus considers Selectis Health to be Significantly Overvalued.

Key valuation signals for GBCS:

  • ROC (Joel Greenblatt) %: 151.94% (8683% above median its 10-year median of 1.73)
  • GF Value™: $2.14 vs. price of $5.30 (147.7% above fair value)
  • GF Score™: 47/100 with 7 warning signs
  • Industry Position: 1118.4% above the Healthcare Providers & Services median (#163 of 668)

No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Selectis Health Business Description

Address 600 17th Street, Suite 284, Denver, CO, USA, 80202
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
47GF Score

Get the complete analysis for GBCS

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.30
Price
$2.14
GF Value